These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 11773182)
1. Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis. Medvedev KE; Savelyeva AV; Chen KS; Bagrodia A; Jia L; Grishin NV Cancer Inform; 2022; 21():11769351221132634. PubMed ID: 36330202 [TBL] [Abstract][Full Text] [Related]
2. Current Management of Refractory Germ Cell Tumors and Future Directions. Allen JC; Kirschner A; Scarpato KR; Morgans AK Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447 [TBL] [Abstract][Full Text] [Related]
3. The present and future of serum diagnostic tests for testicular germ cell tumours. Murray MJ; Huddart RA; Coleman N Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472 [TBL] [Abstract][Full Text] [Related]
4. Pure seminoma: a review and update. Boujelbene N; Cosinschi A; Boujelbene N; Khanfir K; Bhagwati S; Herrmann E; Mirimanoff RO; Ozsahin M; Zouhair A Radiat Oncol; 2011 Aug; 6():90. PubMed ID: 21819630 [TBL] [Abstract][Full Text] [Related]
5. Recurrent seminomas: clinical features and biologic implications. Som A; Zhu R; Guo CC; Efstathiou E; Xiao L; Pisters LL; Matin A; Tu SM Urol Oncol; 2012; 30(4):494-501. PubMed ID: 20822932 [TBL] [Abstract][Full Text] [Related]
6. Update on management of seminoma. Alexander EJ; White IM; Horwich A Indian J Urol; 2010; 26(1):82-91. PubMed ID: 20535292 [TBL] [Abstract][Full Text] [Related]
7. [Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors]. Lorch A; Oechsle K; Bokemeyer C; Beyer J Urologe A; 2009 Apr; 48(4):364-71. PubMed ID: 19255738 [TBL] [Abstract][Full Text] [Related]
8. [Therapy for recurrent testicular cancer]. Kuczyk M; Horstmann M; Merseburger A; Beyer J Urologe A; 2005 Apr; 44(4):352-7. PubMed ID: 15756533 [TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
11. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature. Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942 [TBL] [Abstract][Full Text] [Related]
12. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors. Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340 [TBL] [Abstract][Full Text] [Related]
13. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients. Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518 [TBL] [Abstract][Full Text] [Related]
14. Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. Miller KD; Loehrer PJ; Gonin R; Einhorn LH J Clin Oncol; 1997 Apr; 15(4):1427-31. PubMed ID: 9193335 [TBL] [Abstract][Full Text] [Related]